These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
564 related articles for article (PubMed ID: 22261303)
1. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig. Johnson WB; Katugampola S; Able S; Napier C; Harding SE Life Sci; 2012 Feb; 90(9-10):328-36. PubMed ID: 22261303 [TBL] [Abstract][Full Text] [Related]
2. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. Picq M; Dubois M; Grynberg A; Lagarde M; Prigent AF J Mol Cell Cardiol; 1996 Oct; 28(10):2151-61. PubMed ID: 8930810 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457 [TBL] [Abstract][Full Text] [Related]
4. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. de Vente J; Markerink-van Ittersum M; Vles JS J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445 [TBL] [Abstract][Full Text] [Related]
5. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. Weishaar RE; Quade MM; Schenden JA; Evans DB J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Ko WC; Shih CM; Lai YH; Chen JH; Huang HL Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension. Murray F; MacLean MR; Pyne NJ Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227 [TBL] [Abstract][Full Text] [Related]
8. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis. Torphy TJ; Zhou HL; Burman M; Huang LB Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659 [TBL] [Abstract][Full Text] [Related]
9. Real-time monitoring of phosphodiesterase inhibition in intact cells. Herget S; Lohse MJ; Nikolaev VO Cell Signal; 2008 Aug; 20(8):1423-31. PubMed ID: 18467075 [TBL] [Abstract][Full Text] [Related]
10. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro. Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383 [TBL] [Abstract][Full Text] [Related]
11. Changes in phosphodiesterase activity in the developing rat submandibular gland. Tanaka S; Shimooka S; Shimomura H Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013 [TBL] [Abstract][Full Text] [Related]
12. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors. Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Netherton SJ; Maurice DH Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573 [TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation. Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295 [TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8). Georget M; Mateo P; Vandecasteele G; Lipskaia L; Defer N; Hanoune J; Hoerter J; Lugnier C; Fischmeister R FASEB J; 2003 Aug; 17(11):1380-91. PubMed ID: 12890691 [TBL] [Abstract][Full Text] [Related]
17. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473 [TBL] [Abstract][Full Text] [Related]